Hospital

The management of MDS is primarily targeted at controlling or slowing the disease and preventing future complications as much as possible.

The decline was attributed to continued adherence to infection prevention and control measures.

Metabolic bariatric surgery rates has decreased in response to increased use of glucagon-like peptide-1 (GLP-1) receptor agonists.

Anemia is a very common adverse effect associated with the use of ruxolitinib.

Key trends shaping the future of health-system pharmacy include advanced medication management to address supply chain challenges, digital transformation to enhance pharmacy operations, and strategies for compliance with evolving regulations, all of which will be central topics at the ASHP Midyear 2024 meeting.

Clinicians' enthusiasm for cell and gene therapies is tempered by practical concerns.

These risks were observed to become higher as gestational age decreased.

The study also found that HSSPs minimize health costs and provide additional revenue for health systems.

Jacinda Abdul-Mutakabbir, PharmD, MPH, AAHIVP, discusses a study she conducted that highlights how social determinants of health exacerbate severity and increase rates of mortality from Clostridioides difficile infections in vulnerable communities.

Investigators say basic immunodeficiency screening should be completed in full for this patient population.

The therapy has similar benefits for both older and younger patients with multiple myeloma.

The tumor-agnostic FDA approval of T-DXd for HER2-positive unresectable or metastatic solid malignancies exemplifies the importance of understanding the risks associated with targeted therapy and the need for proactive monitoring strategies.

AI-enabled remote cardiac telemetry can help manage stress’s effects on high-risk populations.

The pharmacist’s role includes determining if there are any medications that are contributing to magnesium deficiency for patients with diabetes who are at an increased risk.

Lipoprotein(a) is a known risk factor for atherosclerotic cardiovascular disease.

Anemia is a common adverse effect of ruxolitinib, calling for new approaches to mitigate risks.

The addition of navitoclax was associated with durable response and potential disease modification.

Pneumococcal disease incidence decreased in adults after pneumococcal vaccines began to be used in children due to indirect protection, with fewer adults found to carry the bacterium that causes disease.

Researchers developed a method to stabilize respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) fusion (F) proteins, advancing potential vaccines for both viruses.

Knowledge of recent intravenous immunoglobulin (IVIG) administration in patients receiving the common laboratory test can help inform misdiagnosis.

In trials, blood pressure reductions were maintained over extended periods, suggesting that the drug could offer a sustained effect.

Methemoglobinemia is a blood disorder that affects proper release of oxygen around the body.

Trends across small cell lung cancer (SCLC) and diffuse large B-cell lymphoma (DLBCL) emphasize the need to further improve global treatment options.

The approval is based on clinical studies that demonstrate the management of heart rate with minimal reductions to blood pressure.

Lisocabtagene maraleucel chimeric antigen receptor T-cell therapy significantly enhances treatment of relapsed/refractory B-cell malignancies, offering high response rates and durable remissions.

Pharmacists are well-positioned to address diabetes from a multifaceted approach.

Although shingles is more common in adults, children who have had chickenpox or the chickenpox vaccine can develop shingles.

However, the monthly expenditure was not significantly associated with the financial incentives.

Pharmacists play a vital role in multidisciplinary health care teams by enhancing medication safety, optimizing therapeutic outcomes, expanding medication access, reducing costs, and improving patient education.

Exposure to pollutants PM2.5 and NO2 was found to increase the likelihood of developing a peanut allergy and of the allergy persisting.